Grace Therapeutics GRCE
NASDAQ GRCE
$1.93 +0.02 (+1.05%)
At close: Oct 23, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Sales of Property, Plant and Equipment (2024)

Updated

Grace Therapeutics' Sales of Property, Plant and Equipment was $1,000 in fiscal Q4 2024 (quarter ended Mar 31, 2024).

Analysis

Grace Therapeutics (GRCE) Sales of Property, Plant and Equipment (2024) Analysis & Trends

For FY2024 (ended Mar 31, 2024), Sales of Property, Plant and Equipment at Grace Therapeutics came in at $111,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -4.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 26.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Grace Therapeutics 31.41 Mn -34.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1,000.00
API Access

Grace Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=GRCE&period=max&api_key=YOUR_API_KEY